- Home
- ALDX vs AMWL Comparison
ALDX vs AMWL Comparison
Compare ALDX & AMWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- AMWL
- Stock Information
- Founded
- ALDX 2004
- AMWL 2006
- Country
- ALDX United States
- AMWL United States
- Employees
- ALDX N/A
- AMWL N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- AMWL Retail: Computer Software & Peripheral Equipment
- Sector
- ALDX Health Care
- AMWL Technology
- Exchange
- ALDX Nasdaq
- AMWL Nasdaq
- Market Cap
- ALDX 133.7M
- AMWL 121.9M
- IPO Year
- ALDX 2014
- AMWL 2020
- Fundamental
- Price
- ALDX $2.15
- AMWL $6.74
- Analyst Decision
- ALDX Strong Buy
- AMWL Hold
- Analyst Count
- ALDX 2
- AMWL 7
- Target Price
- ALDX $9.50
- AMWL $9.67
- AVG Volume (30 Days)
- ALDX 1.2M
- AMWL 54.2K
- Earning Date
- ALDX 05-14-2025
- AMWL 07-30-2025
- Dividend Yield
- ALDX N/A
- AMWL N/A
- EPS Growth
- ALDX N/A
- AMWL N/A
- EPS
- ALDX N/A
- AMWL N/A
- Revenue
- ALDX N/A
- AMWL $261,675,000.00
- Revenue This Year
- ALDX N/A
- AMWL $2.43
- Revenue Next Year
- ALDX N/A
- AMWL $7.30
- P/E Ratio
- ALDX N/A
- AMWL N/A
- Revenue Growth
- ALDX N/A
- AMWL 2.79
- 52 Week Low
- ALDX $1.14
- AMWL $5.00
- 52 Week High
- ALDX $7.20
- AMWL $12.95
- Technical
- Relative Strength Index (RSI)
- ALDX 38.93
- AMWL 41.44
- Support Level
- ALDX $2.15
- AMWL $7.18
- Resistance Level
- ALDX $2.30
- AMWL $7.56
- Average True Range (ATR)
- ALDX 0.15
- AMWL 0.41
- MACD
- ALDX 0.06
- AMWL -0.04
- Stochastic Oscillator
- ALDX 37.93
- AMWL 12.56
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About AMWL American Well Corporation
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others.